Assyro AI

Orange Book product · Generic (ANDA)

WARFARIN SODIUM

WARFARIN SODIUM

Generic (ANDA)ANDA 090935TE ABRX INVAGEN PHARMS

At a glance

May 25, 2011

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 25, 2011

    15 yr 3 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

WARFARIN SODIUM

Strength

1MG

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 090935

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of WARFARIN SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.